The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Cysteine Protease Inhibitors Cure an Experimental Trypanosoma cruzi Infection
Open accessAbstract
Trypanosoma cruzi is the causative agent of Chagas' disease. The major protease, cruzain, is a target for the development of new chemotherapy. We report the first successful treatment of an animal model of Chagas' disease with inhibitors designed to inactivate cruzain. Treatment with fluoromethyl ketone–derivatized pseudopeptides rescued mice from lethal infection. The optimal pseudopeptide scaffold was phenylalanine-homophenylalanine. To achieve cure of infection, this pseudopeptide scaffold was incorporated in a less toxic vinyl sulfone derivative. N-methyl piperazine-Phe-homoPhe-vinyl sulfone phenyl also rescued mice from a lethal infection. Six of the treated mice survived over nine months, three without further treatment. Three mice that had entered the chronic stage of infection were retreated with a 20-d regimen. At the conclusion of the experiments, five of the six mice had repeated negative hemacultures, indicative of parasitological cure. Studies of the effect of inhibitors on the intracellular amastigote form suggest that the life cycle is interrupted because of inhibitor arrest of normal autoproteolytic cruzain processing at the level of the Golgi complex. Parasites recovered from the hearts of treated mice showed the same abnormalities as those treated in vitro. No abnormalities were noted in the Golgi complex of host cells. This study provides proof of concept that cysteine protease inhibitors can be given at therapeutic doses to animals to selectively arrest a parasitic infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Filardi, L. S., & Brener, Z. (1987) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(87)90020-4 · Cited by 549
Microtubules in the Cytoplasm of an Amoeba
HOLBERTON, D. (1969) · Nature · doi:10.1038/222680a0 · Cited by 340
The Crystal Structure of Cruzain: A Therapeutic Target for Chagas' Disease
McGrath, M. E., Eakin, A. E., Engel, J. C., McKerrow, J. H., Craik, C. S., & Fletterick, R. J. (1995) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.0137 · Cited by 269
Self-citationRing, C. S., Sun, E., McKerrow, J. H., Lee, G. K., Rosenthal, P. J., Kuntz, I. D., & Cohen, F. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3583 · Cited by 267
Self-citationRedistribution of alpha-granules and their contents in thrombin-stimulated platelets.
Stenberg, P. E., Shuman, M. A., Levine, S. P., & Bainton, D. F. (1984) · The Journal of cell biology · doi:10.1083/jcb.98.2.748 · Cited by 200
Parada, H., Carrasco, H. A., Añez, N., Fuenmayor, C., & Inglessis, I. (1997) · International Journal of Cardiology · doi:10.1016/s0167-5273(97)02952-5 · Cited by 171
Harth, G., Andrews, N., Mills, A. A., Engel, J. C., Smith, R., & McKerrow, J. H. (1993) · Molecular and Biochemical Parasitology · doi:10.1016/0166-6851(93)90086-d · Cited by 168
Self-citationKjeldsen, L., Bainton, D., Sengeløv, H., & Borregaard, N. (1993) · Blood · doi:10.1182/blood.v82.10.3183.3183 · Cited by 137
Cited by
Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical Biology
Wilcken, R., Zimmermann, M. O., Lange, A., Joerger, A. C., & Boeckler, F. M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3012068 · Cited by 1,331
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
Powers, J. C., Asgian, J. L., Ekici, Ö. D., & James, K. E. (2002) · Chemical Reviews · doi:10.1021/cr010182v · Cited by 1,090
A Critical Review on Chagas Disease Chemotherapy
Coura, J. R., & Castro, S. L. D. (2002) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762002000100001 · Cited by 1,003
Joyce, J. A., Baruch, A., Chehade, K., Meyer-Morse, N., Giraudo, E., Tsai, F.-Y., Greenbaum, D. C., Hager, J. H., Bogyo, M., & Hanahan, D. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00111-4 · Cited by 645
Kinetoplastids: related protozoan pathogens, different diseases
Stuart, K., Brun, R., Croft, S., Fairlamb, A., Gürtler, R. E., McKerrow, J., Reed, S., & Tarleton, R. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33945 · Cited by 604
Self-citationProtease inhibitors targeting coronavirus and filovirus entry
Zhou, Y., Vedantham, P., Lu, K., Agudelo, J., Carrion, R., Nunneley, J. W., Barnard, D., Pöhlmann, S., McKerrow, J. H., Renslo, A. R., et al. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.01.011 · Cited by 583
Self-citationSpecific chemotherapy of Chagas disease: controversies and advances
Urbina, J. A., & Docampo, R. (2003) · Trends in Parasitology · doi:10.1016/j.pt.2003.09.001 · Cited by 567
Mechanism-Based Profiling of Enzyme Families
Evans, M. J., & Cravatt, B. F. (2006) · Chemical Reviews · doi:10.1021/cr050288g · Cited by 564
Lecaille, F., Kaleta, J., & Brömme, D. (2002) · Chemical Reviews · doi:10.1021/cr0101656 · Cited by 519
Specific chemotherapy of Chagas disease: Relevance, current limitations and new approaches
Urbina, J. A. (2010) · Acta Tropica · doi:10.1016/j.actatropica.2009.10.023 · Cited by 473
PROTEASES IN PARASITIC DISEASES
McKerrow, J. H., Caffrey, C., Kelly, B., Loke, P., & Sajid, M. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100151 · Cited by 426
Self-citationDu, X., Guo, C., Hansell, E., Doyle, P. S., Caffrey, C. R., Holler, T. P., McKerrow, J. H., & Cohen, F. E. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010459j · Cited by 381
Self-citationExperimental and Clinical Treatment of Chagas Disease: A Review
Sales Junior, P. A., Molina, I., Fonseca Murta, S. M., Sánchez-Montalvá, A., Salvador, F., Corrêa-Oliveira, R., & Carneiro, C. M. (2017) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.16-0761 · Cited by 305
Vinyl Sulfones as Antiparasitic Agents and a Structural Basis for Drug Design
Kerr, I. D., Lee, J. H., Farady, C. J., Marion, R., Rickert, M., Sajid, M., Pandey, K. C., Caffrey, C. R., Legac, J., Hansell, E., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.014340 · Cited by 294
Self-citationA Role for the Protease Falcipain 1 in Host Cell Invasion by the Human Malaria Parasite
Greenbaum, D. C., Baruch, A., Grainger, M., Bozdech, Z., Medzihradszky, K. F., Engel, J., DeRisi, J., Holder, A. A., & Bogyo, M. (2002) · Science · doi:10.1126/science.1077426 · Cited by 288
Self-citationCysteine Proteinases and the Pathogenesis of Amebiasis
Que, X., & Reed, S. L. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.2.196 · Cited by 280
Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients
Liu, T., Luo, S., Libby, P., & Shi, G.-P. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107587 · Cited by 273
Schistosomiasis Mansoni: Novel Chemotherapy Using a Cysteine Protease Inhibitor
Abdulla, M.-H., Lim, K.-C., Sajid, M., McKerrow, J. H., & Caffrey, C. R. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040014 · Cited by 269
Self-citationMultiple cathepsins promote pro-IL-1β synthesis and NLRP3-mediated IL-1β activation
Orlowski, G. M., Colbert, J. D., Sharma, S., Bogyo, M., Robertson, S. A., & Rock, K. L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500509 · Cited by 268
Divergent modes of enzyme inhibition in a homologous structure-activity series.
Ferreira, R. S., Bryant, C., Ang, K. K. H., McKerrow, J. H., Shoichet, B. K., & Renslo, A. R. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9009229 · Cited by 88
Self-citationBoudreau, P. D., Miller, B. W., McCall, L.-I., Almaliti, J., Reher, R., Hirata, K., Le, T., Siqueira-Neto, J. L., Hook, V., & Gerwick, W. H. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00294 · Cited by 57
Metadata
- Authors
- Engel, J. C., Doyle, P. S., Hsieh, I., & McKerrow, J. H.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1998-08-17
- Volume
- 188
- Issue
- 4
- Pages
- 725-734
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2169156755
- Cited by
- 392
- References
- 15
- FWCI
- 12.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.